Contact this trialFirst, we need to learn more about you.
Anti-metabolites
Genomic Assessment for Mutation Clearance in Acute Myeloid Leukemia
Recruiting1 awardPhase 2
Rochester, New York
This trial will compare the relapse-free and overall survival of patients with leukemia who have cleared their leukemia-associated mutations after standard consolidation chemotherapy to historical controls. The trial will also compare the relapse-free and overall survival of patients who have not cleared their mutations.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.